Abciximab reduces mortality in diabetics following percutaneous coronary intervention

This publication has 47 references indexed in Scilit:

• Diabetes and Decline in Heart Disease Mortality in US Adults
  JAMA, 1999
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• One-Year Outcomes of Diabetic Versus Nondiabetic Patients With Non–Q-Wave Acute Myocardial Infarction Treated With Percutaneous Transluminal Coronary Angioplasty
  The American Journal of Cardiology, 1998
• Comparison of Factors Associated With 30-Day Mortality After Coronary Artery Bypass Grafting in Patients With Versus Without Diabetes Mellitus
  The American Journal of Cardiology, 1998
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010
  Diabetic Medicine, 1997
• Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.
  Circulation, 1997
• Problem of Angioplasty in Diabetics
  Circulation, 1997
• The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress
  The Lancet, 1997
• Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
  Journal of the American College of Cardiology, 1997
• Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction
  Annals of Internal Medicine, 1997